Trial intelligence / Profile preview

Duloxetine for analgesia in hospitalized burn patients

IRCT2017051422637N4Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of duloxetine in burn injury, sponsored by Kerman University of Medical Sciences. Started Jan 2017; status: completed.

02

Drugs

duloxetine
03

Conditions

burn injury

Beyond the preview

Go deeper on IRCT2017051422637N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017051422637N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call